Publication | Closed Access

An ultra performance liquid chromatography–tandem MS assay for tamoxifen metabolites profiling in plasma: First evidence of 4′-hydroxylated metabolites in breast cancer patients

Breast OncologyBiochemistryBreast Cancer PatientsMedicineBioanalysisPharmacologyMetabolomic ProfilingBreast CancerTamoxifen Metabolites4′-Hydroxylated MetabolitesMetabolic ProfilingMetabolomicsCancer MetabolismCancer ResearchDrug Analysis